Transdermal Delivery of Antihypertensive Agents: A tabular update
Keywords:
Transdermal, Antihypertensive agentsAbstract
Transdermal Drug Delivery System is viable drug delivery platform technology and has a strong market world wide. Transdermal Drug Delivery System is particularly desirable for drugs that need prolonged administration at controlled plasma level that basis make appropriateness to antihypertensive agents for their transdermal development. Controlled zero order absorption, easily termination of drug delivery, easy to administration also support for popularity of transdermal delivery. This paper reviews the work on transdermal studies of antihypertensive agents in the tabular form.
References
Robert L. Transdermal Drug Delivery: past
progress, current status, and future
prospects. Adv Drug Del Rev 2004; 56:
-558.
Mitchel JT. Transdermal Drug Deliveryclinical & regulatory strategies, Target
Health Inc., 2000, In American Academy of
Dermatology-58th Annual Meeting.
Jamakandi VD, Ghosh B, Desai BG and
Khanam J. Recent Trends in Transdermal
Cardiovascular Therapy. Ind J Pharma Sci
; 68(5) : 556-561
Thacharodi D and Rao KP. Development
and in vitro evaluation of chitosan-based
transdermal drug delivery systems for the
controlled delivery of propranolol
hydrochloride. Biomat 1995;16: 145..
Chein YW. Novel drug delivery system.
Marcel Dekker, Inc., New York, 1992; 50-
Ghosh B, Reddy LH. Effect of
physicochemical parameters on skin
permeability of antihypertensive. Ind J Exp
Bio 2001; 39: 710.
Anroop B, Ghosh B, Parcha V, Khanam J.
Transdermal delivery of atenolol: effect of
prodrugs and iontophoresis. Curr Drug Del
; 6: 280-290.
Pandit V, Khanum A, Bhaskaran S & Banu
V. Formulation and Evaluation of
transdermal films for the treatment of
Overactive Bladder. Int J PharmTech Res
; 1(3): 799-804.
Omray LK, Kohli S, Khopade AJ,
Gajbhiye A, Agrawal GP. Development of
mesophasic microreservoir-based
transdermal drug delivery system of
propranolol. Ind J Pharma Sci 2008; 70(5):
-584.
Wahid A, Sridhar BK, Shivakumar S,
Preparation and evaluation of transdermal
drug delivery system of etoricoxib using
modified chitosan. Ind J Pharma Sci 2008;
(4): 455-460.
Gajbhiye V, Kumar PV, Sharma A,
Agrawal A, Asthana A, Jain NK.
Dendrimeric nanoarchitectures mediated
transdermal and oral delivery of bioactive.
Indian J Pharm Sci 2008; 70(4): 431–439.
Desai BG, Annamalai AR, Divya B, Dinesh
BM. Effect of enhancers on permeation
kinetics of captopril for transdermal system.
Asian Journal of Pharmaceutics 2008; 2 (1):
-37.
Sadashivaiah R, Dinesh BM, Patil UA,
Desai BG, Raghu KS. Design and in vitro
evaluation of haloperidol lactate
transdermal patches containing ethyl
cellulose- povidone as film formers. Asian
Journal of Pharmaceutics 2008; 2(1): 43-49.
Qureshi MJ, Ali J, Ahuja A, Baboota S.
Formulation strategy for low absorption
window antihypertensive agent. Indian J
Pharm Sci. 2007; 69(3): 360-364.
Jain A, Ghosh B, Rajgor N, Desai BG.
Passive and iontophoretic permeation of
glipizide. Eur J Pharm Biopharm 2008;
(3):958-63.
Singh G, Ghosh B, Kushalkumar D,
Somsekhar V. Screening of vanlafaxine
hydrochloride for transdermal delivery:
passive diffusion and iontophoresis. AAPS
Pharm Sci Tech 2008; 9(3):791-7.
Shinde A, Garala K, More H. Development
and characterization of transdermal
therapeutics system of tramadol
hydrochloride. Asian Journal of
Pharmaceutics 2008; 2(4): 265-269.
Aqil M, Chaudhary BI, Sultan Y,
Talegaonkar S, Ahmad FJ, Aji MM.
Transdermal therapeutic system of enalapril
maleate using piperidine enhancer. Current
Drug Deliv. 2008; 5(2): 148-152.
Gupta A, Prajapati SK, Balamurugan M,
Singh M, Bhatia D. Design and
Development of a Proniosomal Transdermal
Drug Delivery System for Captopril.
Tropical Journal of Pharmaceutical
Research 2007; 6(2): 687-693.
Jain S, Joshi SC. Development of
transdermal matrix system of Captopril
based on cellulose derivative.
Pharmacolgyonline 2007; 379-390.
Trommer H, Neubert RHH. Overcoming
the stratum corneum: The modulation of
skin permeation. 2006; 19: 106-121.
Basak SC. Transdermal Patches: What
pharmacists need know?, The pharma
review in june, 2006.
Aqil M, Ali A, Sultana Y, Dubey K, Najmi
AK, Pillai KK. In Vivo Characterization of
Monolithic Matrix Type Transdermal Drug
Delivery Systems of Pinacidil
Monohydrate: A Technical Note. AAPS
PharmSciTech 2006; 7(1): E1-E5.
Heather A.E. Benson. Transdermal Drug
Delivery: Penetration Enhancement
Techniques, Bentham Science Publishers
Ltd. 2005, 2, 23-33.
Babu RJ and Pandit JK. Effect of
penetration enhancers on the release and
skin permeation of bupranolol from
reservoir-type transdermal delivery systems.
Int J Pharm 2005; 288: 325.
Anroop B, Ghosh B, ParchaV, Kumar A
and Khanam. Synthesis and comparative
skin permeability of atenolol and
propranolol esters. J Drug Del Sci
Tech 2005; 15:187.
Brewster LM, Montfrans GAV, Kleijnen J.
Systematic review: Antihypertensive drug
therapy in blank patients. Ann Intern Med
;141: 614-627.
Grafe F, Wohlrab W, Neubert R and
Brandesh M. Carrier mediated transport of
clonidine in human keratinocytes. Eur J
Pham Sci 2004; 21: 309.
Babu RJ and Pandit JK. Effect of
cyclodextrins on the complexation and
transdermal delivery of bupranolol through
rat skin. Int J Pharm 2004; 271: 155.
Cho CW and Shin SC. Enhanced
transdermal delivery of atenolol from the
ethylene-vinyl acetate matrix. Int J
Pharm 2004; 287: 67.
Wang Z, Itoh Y, Hosaka Y, Kobayashi I,
Nakano Y, Maeda I, Umeda F, Yamakawa
J, Kawase M, Yagi K, Novel Transdermal
Drug Delivery System with
Polyhydroxyalkanoate and Starburst
Polyamidoamine Dendrimer. Journal of
Bioscience and Bioengineering 2003; 95(5):
-543.
Aqil M, Sultana Y, Ali A. Matrix type
transdermal drug delivery system of
metoprolol tartrate: In-vivo
characterization. Acta Pharm 2003; 53:
-125.
Manvi FV, Dandagi PM, Gadad AP,
Mastiholimath VS. Jagadeesh T,
Formulation of transdermal drug delivery
system of ketotifen fumarate. Ind J Pharm
Edu & Res 2003; 65(3): 239-243.
Cross SE, Thompson MJ, Roberts MS.
Transdermal penetration of
vasoconstrictors-present understanding and
assessment of the human epidermal flux and
retention of free bases and ion-pair. Journal
Pharmaceutical Research 2004; 270-274.
Panigrahi L, Ghosal SK. Formulation and
evaluation of pseudolatex transdermal drug
delivery system of terbutaline sulphate. Ind
J Pharm Sci, 2002; 64: 79-82.
